Lexicon Pharmaceuticals
LXRX
LXRX
106 hedge funds and large institutions have $281M invested in Lexicon Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
2.05% less ownership
Funds ownership: 77.08% → 75.03% (-2%)
5% less funds holding
Funds holding: 112 → 106 (-6)
19% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 31
Holders
106
Holding in Top 10
2
Calls
$522K
Puts
$476K
Top Buyers
| 1 | +$6.79M | |
| 2 | +$2.44M | |
| 3 | +$1.2M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.19M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.03M |
Top Sellers
| 1 | -$8.09M | |
| 2 | -$3.45M | |
| 3 | -$2.1M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.24M |
| 5 |
Two Sigma Investments
New York
|
-$677K |